300289 Beijing Leadman Biochemistry
- 4.27
- +0.06+1.43%
Beijing Leadman Biochemistry News
Leadman: Announcement on the acquisition of a medical device registration certificate by its subsidiary Desai Systems
Leadman: Progress Announcement on the Use of Idle Raised Funds for Cash Management
Leadman: CITIC Construction Investment Securities Co., Ltd.\'s inspection opinion on Beijing Leadman Biochemical Co., Ltd. issuing shares to specific targets and restricting the listing and circulation of shares
Leadman: An indicative announcement on the issuance of shares to specific targets and the listing and circulation of restricted shares
Leadman: Announcement on the company\'s acquisition of a patent certificate
Beijing Leadman Biochemistry: Half-year report for the year 2024.
Beijing Leadman Biochemistry: Summary Table of Non-Operating Funds Used and Other Related Fund Transactions for the First Half of 2024.
Beijing Leadman Biochemistry: Announcement of the Supervisory Board's resolution.
Beijing Leadman Biochemistry: Summary of Half-Year Report in 2024.
Beijing Leadman Biochemistry: Announcement Regarding Write-Back of Asset Impairment Provision in the First Half of 2024.
Beijing Leadman Biochemistry: Board of directors resolution announcement.
Beijing Leadman Biochemistry: Interim report disclosure prompt announcement for 2024.
Beijing Leadman Biochemistry: Special report on the use and deposit of funds raised in the first half year of 2024.
Beijing Leadman Biochemistry: Announcement on the Progress of Entrusted Wealth Management with Idle Self-owned Funds
Beijing Leadman Biochemistry: Announcement on the Progress of Overseas Investment.
Beijing Leadman Biochemistry: Announcement on the Progress of Entrusted Wealth Management with Idle Self-owned Funds
Beijing Leadman Biochemistry: Announcement regarding the signing of a supplementary agreement for the house rental contract by the company.
Beijing Leadman Biochemistry: Announcement on the Progress of Entrusted Wealth Management with Idle Self-owned Funds
Beijing Leadman Biochemistry: Announcement on the Progress of Using Idle Funds for Cash Management
Beijing Leadman Biochemistry: Announcement on the Progress of Entrusted Wealth Management with Idle Self-owned Funds
Analysis
Price Target
No Data
No Data